Full name
HELIKON FARMACJA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 56,2 | |||
Gross profit (loss) | -0,1 | -0,6 | -0,7 | -9,4 |
EBITDA | 64,2 | |||
Short time liabilities | -2 | |||
Income tax | 0 | 0 | -0 | -112 |
Other operating costs | -20,6 | |||
Equity capital | -6,5 | -7,1 | -7,8 | -9,5 |
Operating profit (EBIT) | 66,3 | |||
Assets | 0,6 | 0,8 | 0,8 | 7,3 |
Net profit (loss) | -0,1 | -0,6 | -0,7 | -9,1 |
Cash | -12,9 | |||
Liabilities and provisions for liabilities | 7,1 | 7,9 | 8,6 | 9,3 |
Net income from sale | 12,5 | |||
Working assets | 0,6 | 0,7 | 0,8 | 7,5 |
Other income costs | 521,9 | |||
Basic operational activity income | 4,5 | 4,4 | 4,9 | 11,5 |
Depreciation | 24,6 | |||
% | % | % | p.p. | |
Profitability of capital | -2,1 | |||
Equity capital to total assets | -1083,4 | -935,9 | -954,4 | -18,5 |
Gross profit margin | -2,5 | -14,2 | -13,9 | 0,3 |
EBITDA Margin | 2,1 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | -79 | |||
Current financial liquidity indicator | 0 | |||
Net dept to EBITDA | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane